Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Chinese Patent Office
Moodys
Johnson and Johnson
Dow
US Army
Argus Health
Daiichi Sankyo
Covington
Cipla
McKesson

Generated: February 18, 2018

DrugPatentWatch Database Preview

Details for Patent: 5,317,016

« Back to Dashboard

Summary for Patent: 5,317,016
Title: Pyrrolidylthiocarbapenem derivative
Abstract:A pyrrolidylthiocarbapenem derivative represented by Formula I is provided: ##STR1## wherein R.sup.1 is hydrogen or lower alkyl; R.sup.2, R.sup.3 and R.sup.4 are hydrogen, lower alkyl which can be substituted or an amino protecting group independently, or R.sup.2 and R.sup.3 together with a nitrogen atom to which R.sup.2 and R.sup.3 are bonded form a saturated or unsaturated cyclic group, or R.sup.2 and R.sup.4, or R.sup.3 and R.sup.4 together with two nitrogen atoms and one sulfur atom in the sufamide group form a saturated or unsaturated cyclic group; each cyclic group can further include at least one atom selected from the group consisting of oxygen, sulfur and nitrogen, and each cyclic group can be substituted; X.sup.1 is hydrogen or a hydroxy protecting group; X.sup.2 is hydrogen, a carboxy protecting group, an ammonio group, an alkali metal or an alkaline-earth metal; and Y.sup.2 is hydrogen or an amino protecting group.
Inventor(s): Nishitani; Yasuhiro (Osaka, JP), Irie; Tadashi (Osaka, JP)
Assignee: Shionogi Seiyaku Kabushiki Kaisha (Osaka, JP)
Application Number:07/929,961
Patent Claim Types:
see list of patent claims
Compound; Use;

Drugs Protected by US Patent 5,317,016

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 5,317,016

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
Japan3-207972Aug 20, 1991
Japan4-35366Feb 21, 1992

International Patents Family Members for US Patent 5,317,016

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
China 1071428 ➤ Try a Free Trial
China 1032257 ➤ Try a Free Trial
China 1113233 ➤ Try a Free Trial
China 1034571 ➤ Try a Free Trial
China 1078718 ➤ Try a Free Trial
China 1052474 ➤ Try a Free Trial
China 1257068 ➤ Try a Free Trial
China 1222508 ➤ Try a Free Trial
Germany 69231834 ➤ Try a Free Trial
Germany 69307355 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Medtronic
Cipla
Boehringer Ingelheim
Covington
Moodys
Teva
Colorcon
Healthtrust
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot